Filing Details
- Accession Number:
- 0001209191-23-021887
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-31 16:46:50
- Reporting Period:
- 2023-03-30
- Accepted Time:
- 2023-03-31 16:46:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1851194 | Ventyx Biosciences Inc. | VTYX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1575202 | Sheila Gujrathi | C/O Ventyx Biosciences, Inc. 662 Encinitas Blvd., Suite 250 Encinitas CA 92024 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-30 | 100,000 | $6.03 | 100,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-03-30 | 100,000 | $33.73 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2023-03-30 | 100,000 | $0.00 | 100,000 | $6.03 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
662,369 | 2031-08-17 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average share price of an aggregate total of 100,000 shares sold in the price range of $33.50 to $33.97. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Option granted under pursuant to the Issuer's 2019 Equity Incentive Plan, as amended (the "2019 Plan"). Subject to the Reporting Person continuing to be a Service Provider (as defined 2019 Plan) through each applicable date, one twenty-fourth (1/24th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean May 14, 2021.